By Exec Edge Editorial Staff Ascentage Pharma said China’s Center for Drug Evaluation has cleared...

By Daniella Parra Iovance Biotherapeutics said Amtagvi had a 52% response rate with two or...

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued...

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with medical device...

By Karen Roman Ascentage Pharma Group Internat (Nasdaq: AAPG) said its treatment candidate for B-cell...

By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B...

By Karen Roman SkylineDx said it published new peer-reviewed data where its Merlin CP-GEP Test...

By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device...

By Daniella Parra March Bio is developing MB-105, a first-in-class autologous CD5-targeted CAR-T cell therapy for...

Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris...